Several studies have indicated that a variety of different immune cells, including CD4+ and CD8+T -cells, dendritic cells, and tumor-associated macrophages (TAMs), have been identified in different cancers, such as prostate cancer, HCC and others (Pan et al., 2019; Zhang Y. et al., 2020). This evidence concerns the gene CD8A and neoplasm.